FX Update: Can the USD only thrive on distress? FX Update: Can the USD only thrive on distress? FX Update: Can the USD only thrive on distress?

FX Update: Can the USD only thrive on distress?

Forex 5 minutes to read
John Hardy

Head of FX Strategy

Summary:  The US dollar largely shrugged off a weak auction of T-bonds yesterday, but did perk up as risk sentiment suffered a mild, and recently rather rare, setback in the Asian session and early Europe. Indeed, the chief risk for USD bears for a few weeks or more will be the fear that markets have over-positioned for post-Covid and post-vaccination outcomes.

FX Trading focus: USD eases back higher – likely only to find more support on risk aversion
The USD is pushing back to the upside a bit today as risk sentiment is suffering a wobble for once overnight (surely linked to China being off line for a holiday). The risk sentiment angle for the US dollar seems the chief driver as FX largely shrugged off the weak T-bond auction by the US treasury yesterday, which saw yields recovering most of the previous day’s drop. While US long yields are near their highs for the cycle and some 75 basis points from the lowest weekly closes last year, as we noted on this morning’s Saxo Market Call podcast US mortgage rates have only picked up some 10 basis points from their lows in December – as financial and market risk conditions are about as good as they will ever get, certainly from a momentum perspective. And that is where the chief risk for USD bears lies in the near term, that the market is over-positioned for the post-vaccine, post-Covid bounceback.

I outlined a scary scenario for global markets on Wednesday, in which the US dollar heads lower even as long US yields rise aggressively, which would suggest a global loss of faith in the US dollar, one that the Fed would only compound if it thought it could do yield curve control to tamp down the risks of higher yields, as this would only aggravate the USD decline. I don’t consider this scenario likely, though at some point I wonder how US yields at the long end of the curve will behave in the event of a robust recovery starting perhaps in late Q2 as issuance needs from the treasury are far beyond what the Fed is buying or what the treasury has in its account at the Fed beyond perhaps mid-Q3. It would seem to me that a US dollar decline, will have to be a somewhat orderly one, one that proceeds as rising global inflation also makes other currencies look relatively unattractive to real goods (i.e., negative real rates) and requires that they do yield curve control as well as the Fed.

Until then, the US dollar can still catch a bid here and there on risk aversion from concerns that the market has been too aggressive in pricing in the recovery to questions of whether the recovery will prove particularly robust in the first place if the vaccinations are less effective or too slowly rolled out to have meaningful impact until the spring of 2022 rolls around. For Europe, this is a real concern as noted below.

The recent bullish reversal in AUDUSD after interacting with the important 0.7600 area looks a boon to the bulls looking for new highs for the cycle – and perhaps that’s what we’ll get. But if markets have over-positioned for the post-Covid economy, we certainly have an ongoing risk of a significant hitch in the trend before it resumes, and the AUDUSD up-trend first reached these levels well over a month ago, so the momentum has gone stale for now until proven otherwise. Could we have an existential test of the trend back to at least 0.7500 (still just a 38.2% retracement of the rally from the November lows) before an eventual rise to 0.8100 and higher? How quickly commodities return on the path higher after the Chinese New Year (China back on line next Thursday) will provide at least half of the answer.

Source: Saxo Group

Odds and ends
EU vaccination worries – Europe needs to step up the pace of vaccinations in a hurry as it is mired in its double-dip recession and needs to get things moving if Club Med is to have a significant portion of its tourist season saved from another year of lockdowns. Tourism is 15-20% of GDP across the region and a major source of income transfer within the EU. Where is the war-like footing in the EU to get the population vaccinated? Today, Germany announced that it is tightening travel restrictions at its borders with Austria and Czechia on concerns that variant strains of Covid will be spread to the country.

If a consolidation across markets does appear here, I would expect EM and commodity-linked FX to prove the most sensitive (especially AUD and NOK) and for the G3 currencies to remain relatively firm, with the USD at the top of the heap – possibly closely followed by the JPY if US yields remain capped, and then the euro lagging the pack.

Next week, we have a look at FOMC minutes (likely a snoozer), RBA minutes from Australia and a Turkish rate decision that starts to get more interesting now that USDTRY has retreated all the way back to near 7.00 – the big level that was defended last year and then failed in August before President Erdogan allowed the “bitter medicine” of rate hikes to defend the currency. Mexico cut rates yesterday to 4.00%, having the luxury to do so on MXN’s strong resurgence and an economy that will post its a current account surplus for 2020, the first year to do so in modern memory. USDMXN was not reactive and the action there looks bogged down in the 20.00 area – really running out of steam and disappointing if we consider the supportive backdrop for EM risk and risk in general in recent weeks.

Upcoming Economic Calendar Highlights (all times GMT)

  • 0730 – Switzerland Jan. CPI
  • 0800 – Hungary Jan. CPI
  • 0900 – Poland Q4 GDP
  • 1030 – Russian Central Bank announces interest rate
  • 1500 – US Feb. University of Michigan Sentiment


    Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

    The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

    Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

    To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

    None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

    Please read our disclaimers:
    - Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
    - Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
    - Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

    Saxo Capital Markets (Australia) Limited
    Suite 1, Level 14, 9 Castlereagh St
    Sydney NSW 2000

    Contact Saxo

    Select region


    The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

    Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

    Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

    Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

    The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

    Please click here to view our full disclaimer.